Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
Clinical trial NCT00897533 · COMPLETED
Trial details
- NCT number
- NCT00897533
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2007-04-13
- Primary completion
- 2008-04-13
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.